Search

Evidence of the effectiveness of dietary behavior interventions in patients with non-dialysis chronic kidney disease is limited. We aim to determine the benefits and barriers of dietary behavior interventions for this population. Eligible studies were obtained from databases including PubMed, Embase, the Cochrane Library, Web of Science, and CINAHL. Six studies including 432 participants were identified. Overall, dietary behavior interventions significant improved adherence to protein intake (2.64, 95% CI 1.33, 5.23, I 2 = 0) and renal function (eGFR) (2.97, 95% CI 2.59, 3.35, I 2 = 0). Moreover, dietary behavior interventions indicated a significant opportunity to promote adherence to sodium-restricted diets (SRD), blood pressure (BP), self-efficacy, and quality of life (QoL) in non-dialysis CKD patients. However, there is still need to determine dietary behavior intervention programs in large sample and amount of studies, develop reliable instruments to measure dietary adherence, and thereafter, provide more reliable results for clinical practice. [ABSTRACT FROM AUTHOR]

Depressive symptoms are common in patients with end-stage renal disease, which can affect treatment and prognosis. We aimed to evaluate the effects of nonpharmacological interventions for depressive symptoms in end-stage renal disease. Eligible studies were identified using PubMed, Web of Science, the Cochrane Library, Embase, and PsycNET (up to March 2019). We identified 24 studies including 1,376 patients. We found that psychological intervention (−0.60, 95% confidence interval [CI] = [–0.87, –0.33]), exercise (−1.13, 95% CI = [–1.56, –0.69]), and manual acupressure (−0.26, 95% CI = [–0.50, 0.03]) were associated with a significant effect on depressive symptoms. However, few studies reported adverse events, and conclusions about safety should be drawn cautiously. While the available data show that nonpharmacological interventions are potential strategies to alleviate depressive symptoms of patients with end-stage renal disease, recommendation of the most efficacious interventions for this population will require future randomized controlled trials with large-scale, long-term intervention. [ABSTRACT FROM AUTHOR]